tiprankstipranks
Trending News
More News >
Takara Bio Inc. (JP:4974)
:4974
Japanese Market

Takara Bio Inc. (4974) Stock Forecast & Price Target

Compare
2 Followers
See the Price Targets and Ratings of:

4974 Analyst Ratings

Hold
3Ratings
Hold
0 Buy
3 Hold
0 Sell
Based on 3 analysts giving stock ratings to
Takara
Bio Inc.
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

4974 Stock 12 Month Forecast

Average Price Target

¥800.33
▼(-0.08%Downside)
Based on 3 Wall Street analysts offering 12 month price targets for Takara Bio Inc. in the last 3 months. The average price target is ¥800.33 with a high forecast of ¥830.00 and a low forecast of ¥780.00. The average price target represents a -0.08% change from the last price of ¥801.00.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"779":"¥779","1204":"¥1,204","885.25":"¥885.3","991.5":"¥991.5","1097.75":"¥1,097.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":830,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">¥830.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":800.33,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">¥800.33</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":780,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">¥780.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[779,885.25,991.5,1097.75,1204],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Apr<br/>2024","6":"Jul<br/>2024","9":"Oct<br/>2024","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,794,796.7692307692307,799.5384615384615,802.3076923076923,805.0769230769231,807.8461538461538,810.6153846153846,813.3846153846154,816.1538461538462,818.9230769230769,821.6923076923077,824.4615384615385,827.2307692307693,{"y":830,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,794,794.4869230769231,794.9738461538461,795.4607692307692,795.9476923076924,796.4346153846154,796.9215384615385,797.4084615384616,797.8953846153846,798.3823076923077,798.8692307692309,799.3561538461539,799.843076923077,{"y":800.33,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,794,792.9230769230769,791.8461538461538,790.7692307692307,789.6923076923077,788.6153846153846,787.5384615384615,786.4615384615385,785.3846153846154,784.3076923076923,783.2307692307693,782.1538461538462,781.0769230769231,{"y":780,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1203.38,"date":1704067200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1195.67,"date":1706745600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":962.51,"date":1709251200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":947.06,"date":1711929600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":995.1,"date":1714521600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1002.94,"date":1717200000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1064.7,"date":1719792000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1093.14,"date":1722470400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":997.06,"date":1725148800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1031.37,"date":1727740800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":979.41,"date":1730419200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":979.41,"date":1730419200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":794,"date":1748736000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target¥830.00Average Price Target¥800.33Lowest Price Target¥780.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on JP:4974
TipRanks AITipRanks
Not Ranked
TipRanks
¥846
Hold
5.62%
Upside
Reiterated
07/09/25
Takara Bio Inc.'s stock is supported by strong financial stability and moderate technical indicators suggesting short-term positivity. However, challenges in profitability and high valuation relative to earnings limit the potential upside. The company's negative free cash flow and high P/E ratio are significant risks that need addressing to improve the stock's attractiveness.
Citi
¥900¥830
Hold
3.62%
Upside
Reiterated
06/26/25
Citi Remains a Hold on Takara Bio Inc. (4974)
Nomura
¥1,000¥780
Hold
-2.62%
Downside
Reiterated
06/12/25
Nomura Reaffirms Their Hold Rating on Takara Bio Inc. (4974)
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on JP:4974
TipRanks AITipRanks
Not Ranked
TipRanks
¥846
Hold
5.62%
Upside
Reiterated
07/09/25
Takara Bio Inc.'s stock is supported by strong financial stability and moderate technical indicators suggesting short-term positivity. However, challenges in profitability and high valuation relative to earnings limit the potential upside. The company's negative free cash flow and high P/E ratio are significant risks that need addressing to improve the stock's attractiveness.
Citi
¥900¥830
Hold
3.62%
Upside
Reiterated
06/26/25
Citi Remains a Hold on Takara Bio Inc. (4974)
Nomura
¥1,000¥780
Hold
-2.62%
Downside
Reiterated
06/12/25
Nomura Reaffirms Their Hold Rating on Takara Bio Inc. (4974)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

4974 Analyst Recommendation Trends

Rating
Nov 24
Jun 25
Strong Buy
0
0
Buy
0
0
Hold
1
3
Sell
0
0
Strong Sell
0
0
total
1
3
In the current month, 4974 has received 0 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. 4974 average Analyst price target in the past 3 months is 800.33.
Each month's total comprises the sum of three months' worth of ratings.

4974 Financial Forecast

4974 Earnings Forecast

The previous quarter’s earnings for 4974 were ¥20.10.
The previous quarter’s earnings for 4974 were ¥20.10.

4974 Sales Forecast

Next quarter’s sales forecast for 4974 is ¥8.34B with a range of ¥7.60B to ¥9.08B. The previous quarter’s sales results were ¥15.76B. 4974 beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year 4974 has Outperformed its overall industry.
Next quarter’s sales forecast for 4974 is ¥8.34B with a range of ¥7.60B to ¥9.08B. The previous quarter’s sales results were ¥15.76B. 4974 beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year 4974 has Outperformed its overall industry.

4974 Stock Forecast FAQ

What is JP:4974’s average 12-month price target, according to analysts?
Based on analyst ratings, Takara Bio Inc.’s 12-month average price target is 800.33.
    What is JP:4974’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for JP:4974, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Takara Bio Inc. a Buy, Sell or Hold?
        Takara Bio Inc. has a consensus rating of Hold, which is based on 0 buy ratings, 3 hold ratings and 0 sell ratings.
          What is Takara Bio Inc.’s share price target?
          The average share price target for Takara Bio Inc. is 800.33. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is ¥830.00 ,and the lowest forecast is ¥780.00. The average share price target represents -0.08% Decrease from the current price of ¥801.
            What do analysts say about Takara Bio Inc.?
            Takara Bio Inc.’s analyst rating consensus is a Hold. This is based on the ratings of 3 Wall Streets Analysts.
              How can I buy shares of Takara Bio Inc.?
              To buy shares of JP:4974, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis